Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam

Pranita D. Tamma; Yunfan Fan; Yehudit Bergman; Anna C. Sick-Samuels; Alice J. Hsu; Winston Timp; Patricia J. Simner; Bonnie C. Prokesch; David E. Greenberg

doi:10.1128/AAC.02213-17

Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam

Pranita D. Tamma, Yunfan Fan, Yehudit Bergman, Anna C. Sick-Samuels, Alice J. Hsu, Winston Timp, Patricia J. Simner, Bonnie C. Prokesch, David E. Greenberg

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Wholegenome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.

Original language	English (US)
Article number	e02213-17
Journal	Antimicrobial agents and chemotherapy
Volume	62
Issue number	4
DOIs	https://doi.org/10.1128/AAC.02213-17
State	Published - Apr 2018

Keywords

Bacteremia
Burkholderia cepacia complex
Ceftazidime-avibactam
Whole-genome sequencing

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.02213-17

Fingerprint Dive into the research topics of 'Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam'. Together they form a unique fingerprint.

Cite this

Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam. / Tamma, Pranita D.; Fan, Yunfan; Bergman, Yehudit; Sick-Samuels, Anna C.; Hsu, Alice J.; Timp, Winston; Simner, Patricia J.; Prokesch, Bonnie C.; Greenberg, David E.

In: Antimicrobial agents and chemotherapy, Vol. 62, No. 4, e02213-17, 04.2018.

Research output: Contribution to journal › Article › peer-review

@article{a874f08f6de340779e69f19de4b4a1cc,

title = "Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam",

abstract = "We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Wholegenome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.",

keywords = "Bacteremia, Burkholderia cepacia complex, Ceftazidime-avibactam, Whole-genome sequencing",

author = "Tamma, {Pranita D.} and Yunfan Fan and Yehudit Bergman and Sick-Samuels, {Anna C.} and Hsu, {Alice J.} and Winston Timp and Simner, {Patricia J.} and Prokesch, {Bonnie C.} and Greenberg, {David E.}",

note = "Funding Information: The case study was supported by funding from the National Institutes of Health (grant K23-AI127935 awarded to P.D.T. and grant R21-AI130608 awarded to P.J.S.). None of the case authors report any conflicts of interest.",

year = "2018",

month = apr,

doi = "10.1128/AAC.02213-17",

language = "English (US)",

volume = "62",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam

AU - Tamma, Pranita D.

AU - Fan, Yunfan

AU - Bergman, Yehudit

AU - Sick-Samuels, Anna C.

AU - Hsu, Alice J.

AU - Timp, Winston

AU - Simner, Patricia J.

AU - Prokesch, Bonnie C.

AU - Greenberg, David E.

N1 - Funding Information: The case study was supported by funding from the National Institutes of Health (grant K23-AI127935 awarded to P.D.T. and grant R21-AI130608 awarded to P.J.S.). None of the case authors report any conflicts of interest.

PY - 2018/4

Y1 - 2018/4

N2 - We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Wholegenome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.

AB - We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Wholegenome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.

KW - Bacteremia

KW - Burkholderia cepacia complex

KW - Ceftazidime-avibactam

KW - Whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85044508564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044508564&partnerID=8YFLogxK

U2 - 10.1128/AAC.02213-17

DO - 10.1128/AAC.02213-17

M3 - Article

C2 - 29588357

AN - SCOPUS:85044508564

VL - 62

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

M1 - e02213-17

ER -